Roche tests Swissie demand with Sfr975m deal
◆ Pharma company prints 5.3, 10 and 15 year bonds ◆ Biggest domestic corporate deal in Swiss francs this year ◆ Roche pushes pricing and size in shorter tranches
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts